Your pipeline took a decade.
Your firm selection took a phone call.
Life sciences and pharmaceutical companies manage massive outside counsel spend across IP portfolios, regulatory enforcement, and product liability. Clinical trial litigation, patent challenges worth billions, and FDA/EMA compliance matters demand structured cost discipline — not ad hoc firm selection. Novartis, Moderna, and Sanofi use PERSUIT to bring competitive rigor to every outside counsel engagement — from patent cliff litigation to regulatory investigations. Because when your patent portfolio is worth more than your revenue, you can't afford to leave counsel selection to chance.
Three pressures
every pharma GC
is managing at once.
These aren't generic legal department problems. They're specific to life sciences — shaped by patent cliffs, multi-jurisdiction regulatory regimes, and the exposure that comes with products consumed by millions of patients worldwide.
PERSUIT was built for exactly this environment. Not adapted from a general procurement tool. Built for the IP complexity, regulatory depth, and litigation scale of a global pharmaceutical or life sciences legal function.
Patent cliff litigation puts billions at stake
ANDA challenges, IPR proceedings, Hatch-Waxman litigation, biosimilar disputes. When a single patent challenge can threaten billions in annual revenue, outside counsel selection for IP matters can't be based on historical relationships alone. Your firm selection process needs to be as rigorous as the litigation itself.
Regulatory enforcement spans every jurisdiction
FDA warning letters, EMA compliance actions, MHRA inspections, DOJ investigations, False Claims Act exposure. Life sciences companies face regulatory scrutiny across every market they operate in. Managing dozens of law firms across dozens of jurisdictions without a structured process isn't governance — it's guesswork.
Product liability exposure is existential
Class actions, mass torts, MDL proceedings, individual injury claims. Product liability litigation in pharma can run for decades and involve thousands of plaintiffs. The question isn't whether you'll face it, but whether your outside counsel management can scale to meet it — with cost visibility, firm accountability, and documented selection at every stage.
Portfolio coordination
that scales with
your pipeline.
Most pharma legal functions manage IP portfolios across dozens of firms and jurisdictions. Far fewer have a system that connects patent litigation strategy to outside counsel selection and cost management.
PERSUIT turns your panel from a list of preferred IP and regulatory firms into a coordinated competitive process — with documented firm selection, structured proposal comparison, and full visibility across your entire litigation and compliance portfolio.
Coordinate patent dispute counsel
Patent litigation matters start with a defined scope — jurisdiction, patent family, dispute type, and budget — before a firm is engaged. Requests go to qualified IP firms with consistent information, enabling apples-to-apples comparison on experience, strategy, and fees.
Structure regulatory matter selection
FDA enforcement responses, EMA compliance proceedings, and DOJ investigations each require different expertise. PERSUIT enables structured competitive selection by regulatory body, matter type, and jurisdiction — so the right firm is chosen for the right reason, not just availability.
Manage product liability at scale
Mass tort and class action matters require coordinated counsel management across dozens of firms and thousands of claims. PERSUIT provides cost visibility, billing rule enforcement, and firm performance tracking across your entire product liability portfolio.
Track compliance investigations across the full lifecycle
From initial inquiry to resolution, compliance investigations require documented firm selection, budget governance, and full audit trails. PERSUIT captures every decision — who was considered, why they were selected, and what was agreed — available on demand for internal audit and regulatory review.
Clinical trial compliance.
For the pharma teams
who need it.
Clinical trial legal work — investigator site agreements, CRO contracts, regulatory submissions, data privacy compliance — generates significant outside counsel spend that is often managed without competitive process or cost visibility. When your pipeline depends on trial timelines, counsel selection can't be the bottleneck.
PERSUIT enables life sciences legal teams to competitively source clinical regulatory work, manage investigator site agreement counsel, and maintain full audit trails on every engagement — with the security and compliance documentation your procurement team requires.
Access the Trust Center →The matter types that shape your spend.
Outside counsel spend in life sciences is dominated by a small number of high-stakes matter categories. Here's how PERSUIT changes the economics of each one.
Patent Litigation
ANDA challenges, IPR proceedings, biosimilar disputes, and patent portfolio prosecution. When a single patent family can protect billions in revenue, outside counsel selection needs to be as rigorous as the science itself. PERSUIT structures the competitive process across your entire IP portfolio.
Regulatory Enforcement
FDA warning letters, DOJ investigations, False Claims Act defense, EMA compliance proceedings. Regulatory matters in pharma are high-stakes and multi-jurisdictional. PERSUIT enables rapid competitive selection so enforcement responses get the right firm — not just the first available one.
Product Liability
Mass tort coordination, MDL proceedings, class actions, and individual injury claims. Product liability spend in pharma can span decades and involve coordinated counsel across dozens of jurisdictions. PERSUIT provides portfolio-wide cost visibility and firm performance tracking at scale.
M&A Due Diligence
Pharma M&A requires deep IP due diligence, regulatory transfer analysis, and licensing review. PERSUIT's competitive process ensures your transaction counsel is selected on experience and value — with structured responses that make scope and fees transparent before the engagement begins.
Security that passes
your review,
not just ours.
Life sciences and pharmaceutical companies run rigorous third-party vendor assessments — driven by data sensitivity, IP protection requirements, and regulatory obligations. PERSUIT has passed the security reviews of some of the world's largest pharma companies. Here's what their teams found.
Information Security Management
Certified against the current version of the international ISMS standard. Independently audited. Not self-assessed.
Audited Controls
SOC 1 Type 2 attested. SOC 2 report available under NDA via the PERSUIT Trust Center — alongside pentest report, network diagram, and data flow documentation.
Cloud Security
Cloud Security Alliance STAR certified. Hosted on Google Cloud. SecurityScorecard: A. UpGuard: 865/950. Third-party scores, independently assigned.
FS Outsourcing Compliance
OSPAR document available for Singapore and Hong Kong regulated institutions. One of a very small number of legal technology platforms with this documentation in place.
SSO & Role-Based Permissions
SSO support. Role-based access controls. Full audit logging on every platform action. Your matter data is strictly isolated — no cross-customer data access, ever.
BC/DR & Data Governance
Business Continuity and Disaster Recovery policy in place with tested contingency planning. Encryption policy, acceptable use policy, and full data chain of custody documentation available.
See what life sciences legal teams are achieving.
We'll show you what a PERSUIT demo looks like for a life sciences legal function — IP portfolio management, regulatory matter sourcing, product liability coordination, and what the CFO conversation looks like when you have the data.